<unk>  (Agrylin/Xagrid, Shire and Thromboreductin, AOP Orphan Pharmaceuticals AG) is a drug used for the treatment of essential thrombocytosis (also known as essential thrombocythemia), or overproduction of blood platelets. It also has been used in the treatment of chronic myeloid leukemia.<unk>  controlled release (GALE-401) is in phase III clinical trials by Galena Biopharma for the treatment of essential thrombocytosis.
Anagrelide
Niclosamide
Epitiostanol
Pentoxifylline
Palladin
Gadoteric acid
Elinogrel
Sulfatide